美股异动 | Ocugen(OCGN.US)盘前涨逾40%，与Bharat Biotech共同开发的新冠疫苗中期有效性为81%-To The Moon - Tiger Brokers Online Investing Community

Like
1
Favorite

美股异动 | Ocugen(OCGN.US)盘前涨逾40%，与Bharat Biotech共同开发的新冠疫苗中期有效性为81%

智通财经网2021-03-03

智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

琪琪小不点
·2021-03-03
???
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2116549921?lang=en_US&edition=fundamental","thumbnail":"https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d","is_english":false,"pubTime":"2021-03-03 19:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2116549921","market":"us","top_or_hot":-1,"title":"美股异动 | Ocugen(OCGN.US)盘前涨逾40%，与Bharat Biotech共同开发的新冠疫苗中期有效性为81%","media":"智通财经网","content":"<div>\n<p>智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b\">Source Link</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股异动 | Ocugen(OCGN.US)盘前涨逾40%，与Bharat Biotech共同开发的新冠疫苗中期有效性为81%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股异动 | Ocugen(OCGN.US)盘前涨逾40%，与Bharat Biotech共同开发的新冠疫苗中期有效性为81%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-03 19:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OCGN","symbol_name":"Ocugen","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b","article_id":"2116549921","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2116549921","pubTimestamp":1614771676,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"OCGN":"Ocugen"},"translate_title":"U.S. stock exchange Ocugen (OCGN.US) rose more than 40% before the session, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OCGN":0.9},"content_text":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":365429140,"gmtCreate":1614772694980,"gmtModify":1704775019718,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3566178813813075","idStr":"3566178813813075"},"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/365429140","repostId":2116549921,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}